MAIA Biotechnology (MAIA) Other Operating Expenses (2021 - 2025)
MAIA Biotechnology (MAIA) posted quarterly Other Operating Expenses of $688510.0 for Q4 2025, down 51.94% year-over-year from $1.4 million in Q4 2024, and up 50.42% quarter-over-quarter from $457737.0 in Q3 2025.
MAIA Biotechnology (MAIA) Other Operating Expenses (2021 - 2025) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Other Operating Expenses for 5 consecutive years, with $688510.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses fell 51.94% year-over-year to $688510.0; the TTM figure through Mar 2026 stood at $965342.0 (up 175.97% YoY), while the FY2025 annual figure was $1.9 million, up 129.75% from the prior year.
- Other Operating Expenses climbed to $688510.0 in Q4 2025 per MAIA's latest filing, from $457737.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.5 million in Q3 2024 and bottomed at -$5.1 million in Q2 2024.
- Historically, Other Operating Expenses has averaged -$443595.4 across 5 years, with a median of $106677.0 in 2021.
- On a YoY basis, Other Operating Expenses climbed as much as 1717.87% in 2024 and fell as far as 6213.01% in 2024.
- MAIA Biotechnology's Other Operating Expenses stood at $106677.0 in 2021, then tumbled by 53.81% to $49275.0 in 2022, then jumped by 145.93% to $121180.0 in 2023, then soared by 1082.26% to $1.4 million in 2024, then slumped by 51.94% to $688510.0 in 2025.
- Business Quant data shows MAIA's Other Operating Expenses at $688510.0 in Q4 2025, $457737.0 in Q3 2025, and -$180905.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 688,510.00 |
| Sep 30, 2025 | 457,737.00 |
| Jun 30, 2025 | -180,905.00 |
| Mar 31, 2025 | 908,172.00 |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | -5.06 Mn |
| Mar 31, 2024 | -4.12 Mn |
| Dec 31, 2023 | 121,180.00 |
| Sep 30, 2023 | 79,900.00 |
| Jun 30, 2023 | 141,022.00 |
| Mar 31, 2023 | 67,374.00 |
| Dec 31, 2022 | 49,275.00 |
| Sep 30, 2022 | 191,773.00 |
| Jun 30, 2022 | 136,161.00 |
| Mar 31, 2022 | 29,713.00 |
| Dec 31, 2021 | 106,677.00 |
| Sep 30, 2021 | -2.97 Mn |
| Jun 30, 2021 | -1.96 Mn |